Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic ...

KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation ...
Morning Overview on MSN

Microscopic droplets reveal DNA’s hidden architecture

Inside every human cell, six feet of DNA folds into a nucleus that is only a few micrometers wide, yet still manages to switch genes on and off with exquisite precision. The latest work on ...
Science Daily

Scientists capture most detailed look inside DNA droplets

High-resolution imaging has revealed the internal layout of chromatin condensates, showing how DNA fibers fold and interact ...